AnalysisLead story
Cytiva flags the data bottleneck stalling AI drug discovery
AI can design candidates from scratch, but training data gaps and lab automation limits keep the first AI-designed drug 2 to 3 years from FDA approval.
Jaeden SchaferEditor in Chief5 min read